Use of immunosuppressants/immunomodulators in autoimmune/inflammatory dermatologic diseases during C...
Use of immunosuppressants/immunomodulators in autoimmune/inflammatory dermatologic diseases during COVID-19 pandemic-General recommendation based on available evidence
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Alternative Titles
Full title
Use of immunosuppressants/immunomodulators in autoimmune/inflammatory dermatologic diseases during COVID-19 pandemic-General recommendation based on available evidence
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_37796507c46240318cadb3c2e1d63bc1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37796507c46240318cadb3c2e1d63bc1
Other Identifiers
ISSN
2229-5178
E-ISSN
2249-5673
DOI
10.4103/idoj.IDOJ_414_20